CTRI/2022/07/043943尚未招募未知
A Randomized, Placebo-Controlled, Double Blind, Three Arms, Parallel, Single-Center Study of the Safety and Efficacy of Blessing (Prayer)/Proprietary Therapy (Biofield Energy Healing Therapy) for Improving Physiological Function, Psychological, Emotional and Mental Health as well as Wellness in Adult Subjects for a better Quality of Life.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Males or females between 20 to 55 years of age (both inclusive) at the time of consent.
- •2.Volunteers with a skin reflection of >6% measured via an AGE reader during screening.
- •3.Volunteers with at least one sign and symptom/complaint in at least five or more questions in attachment I and II (for screening) and five of the twelve categories mentioned in the psychological questionnaire in attachment III (for enrollment of the subjects in the study) which broadly include the following:
- •Physical Health
- •Joint pain
- •Exhaustion
- •Low energy
- •Muscle pain
- •Constipation
- •Poor Digestion
- •Aches and pain
- •Chronic fatigue
- •General weakness
- •Appetite problems
- •Poor quality of skin
- •Laziness and lethargy
- •Poor quality and growth of hair
- •Poor quality and growth of nails
- •Grogginess
- •Sleep Apnea
- •Disorientation
- •Heavy Headed
- •Sleep disturbances
- •Poor quality of Sleep
- •Not feeling refreshed on waking up in the morning
- •Irritability
- •Depression
- •Panic attacks
- •Hopelessness
- •Loss of income
- •Constant worry
- •Poor concentration
- •Fear of the Unknown
- •Cognition and Memory
- •Mental fog
- •ADD / ADHD
- •Indecisiveness
- •Difficulty Learning
- •Delusional thinking
- •Poor Memory (short/long term)
- •Inability to Focus / Concentration
- •Lack of Mental Peace / Calmness
- •Mental Restlessness / Mind Chatter
- •Poor Status of Alertness and Awareness
- •Lack of Judgment and Decision-making ability
- •Mental Health
- •Depression
- •Indiscipline
- •Mood swings
- •Stress / Tension
- 另有 31 项未显示
排除标准
- •1.History within the last year or current problems with alcohol dependence or drug abuse.
- •2.Significant diseases or clinically significant abnormal findings in medical history, physical examination, laboratory evaluations, etc., during screening.
- •3.self-tanning agents within 10 days prior to screening. Regular vigorous aerobic/endurance exercise ( >3 vigorous bouts/week).
- •Note: Subjects performing exercise (except vigorous aerobic/endurance exercise >3 vigorous bouts/week) can be enrolled in the study if they agree to perform the same during the entire study period.
- •4.Volunteers receiving treatment for any of the complaints mentioned in inclusion criteria no. 3.
- •5.Known history of positive HIV, HCV, HBsAg or VDRL/RPR results.
- •6.Volunteers with non-healthy, non-homogenous or damaged skin over the measuring area used during the AGE reading.
- •7.Volunteers with birthmarks or excessive hair over the skin of the measuring area used during the AGE reading that can influence the results.
- •8. Volunteers who have used
- •9. Female volunteers with a positive pregnancy test, or who are currently breast-feeding or planning for pregnancy.
- •10.Any other acute or chronic illness that could compromise the integrity of the study data or place the subject at risk by participating in the study.
研究者
相似试验
尚未招募
不适用
A study for Improving Physiological Function, Psychological, Emotional and Mental Health as well as Wellness in Adult Subjects for a better Quality of Life.CTRI/2022/07/043736Trivedi Global Inc
尚未招募
不适用
An observational study for Improving Physiological Function, Psychological, Emotional and Mental HealthCTRI/2022/07/043633Trivedi Global Inc
已完成
3 期
To understand the safety and efficacy of Maxicuma® 100 Capsules and Maxicuma® 250 Capsules in patients suffering from knee pain. ?CTRI/2023/04/052147India Glycols Ltd180
招募中
Unknown
clinical Study of Pimecrolimus cream in Atopic dermatitis patients in IndiaCTRI/2024/03/063709Encube Ethicals Private Limited
已完成
1 期
Bioequivalence Study of Pimecrolimus cream in Atopic dermatitis patientsCTRI/2018/11/016271Encube Ethicals Private Ltd588